ICMR recommends use of anti-malaria drug hydroxychloriquine for treating high-risk COVID-19 patients
The high risk population who would be eligible for getting the drug include asymptomatic healthcare workers involved in the care of suspected or confirmed COVID-19 cases and asymptomatic household contacts of laboratory confirmed cases.